Background: identifying brain changes in schizophrenia has been a majo
r research focus for many years. Although impressive gains have been m
ade in neuroimaging and brain electrophysiology, molecular and cellula
r markers of schizophrenia have lagged. There are no consistent bioche
mical markers for schizophrenia pathophysiology and none that reflect
treatment course, Methods: Samples were obtained from 25 postmortem sc
hizophrenic brains and 31 nonschizophrenic controls, These samples wer
e processed, and the synaptosomal fraction was isolated. Ten microgram
s of protein from each of these samples was solubilized in a sodium do
decylsulfate sample buffer and separated on 10% (wt/vol) polyacrylamid
e gels. Monoclonal antibody (SMI-81) was incubated with the blots and,
using quantitative Western blotting we measured the relative amounts
of SNAP-25 in these samples. Results: We report altered levels of SNAP
-25 in both the inferior temporal cortex (Brodmann area 20) and prefro
ntal association cortex (Brodmann areas 9 and 10) in postmortem brains
of patients with schizophrenia relative to nonschizophrenic controls.
Normal levels of SNAP-25 are noted in schizophrenics in area 17, decr
eased levels in areas 10 and 20, and an elevated level in area 9, Conc
lusions: These data support cytoarchitectural observations that the ce
rebral cortex of schizophrenic patients has extensive pathology. The d
ata presented here, along with data on other brain-specific proteins,
indicate a complicated molecular adaptation to the causative factors o
f schizophrenia. (C) 1998 Society of Biological Psychiatry.